Comparing how three adhesive dressings stay on the skin
Official title: A Healthy Volunteer, Single Center, Exploratory Investigation to Evaluate Wearing Properties of Three Different Non-sterile Silicone Self-adhesive Investigational Devices
Run by Molnlycke Health Care AB · NCT07034014 · Data updated 2026-11-12
We will test how well three different self-adhesive dressings stick to and stay on the back of healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 35 (estimated) |
| Sponsor | Molnlycke Health Care AB Industry-sponsored |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Schenefeld, Free and Hanseatic City of Hamburg) |
| Status | Recruiting |
| Started | June 5, 2025 |
| Main results expected | July 2025 |
| Study ends | August 2025 |
| Registry record updated | June 24, 2025 |
| Trial ID | NCT07034014 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults with intact, minimally hairy skin on the back who can follow visit schedules and avoid wetting or using detergents on the application sites.
✕Probably not a fit
People with known allergies to dressing components, existing skin problems at the application sites, or who cannot avoid washing or using detergents on the sites are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Healthy adult volunteers will have three different adhesive dressings applied to defined sites on the back and monitored over the course of the visit schedule. The study compares two investigational devices to a reference test specimen for their wearing and self-adhesive properties. Investigators will confirm intact skin and minimal hair at application sites before enrollment and will monitor the sites for adhesion and any skin reactions. Participants must avoid wetting or applying detergents to the application sites for the study duration and return for protocol-specified assessments.
Why it matters
Potential benefit: If successful, the results could identify dressing designs that stay attached longer and reduce the need for frequent replacements.
How similar studies have gone: Adhesion and wearability tests like this are commonly used to improve dressing design, though these specific investigational devices are being tested individually.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants who are capable and willing to comply with protocol visits, assessments, and instructions. * Participants must be in general good health with healthy and intact skin in the test area (as determined by the investigator based on medical history and examination of the application sites). * Minimal hairiness at the back (location of the application sites). * Signed written informed consent. Exclusion Criteria: * Known allergy/hypersensitivity to the dressing or its components. * Participants with any features at the application sites will be in contact with the adhesive surface of the dressing, and could influence the investigation. * Participants not willing to avoid contact of the application sites with water in the morning prior to dressing application and throughout the entire course of the study. * Participants not willing to avoid applying any detergents to the application sites in the morning prior to dressing application and throughout the entire course of the study. * Participants not willing to avoid the use of leave on cosmetics such as creams/lotions and sunscreens at the application sites 3 days leading up to dressing application and throughout the entire course of the study. * Participants not willing to refrain from activities which may directly affect the dressings, application sites or assessments in the morning prior to dressing application and throughout the entire course of the study. * Participants whose back is not large enough to accommodate all 12 application sites * Any severe systemic disease that may interfere with the performance, evaluation, and outcome of the investigation as judged by the investigator. * Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years. * Active skin disease at the application sites . * Any topical medication at the application sites within the last 24 hours prior to the start of the test and/or throughout the entire course of the investigation. * Pain relief medication on assessment visits . If it is essential for the participant to take pain relief medication on the days mentioned above for any unforeseen reasons, the participant is allowed to use pain relief medication but has to report this to the study center in order to be documented as protocol deviation. * Pregnancy or lactation. * Drug addicts, alcoholics. * AIDS, HIV-positive or infectious hepatitis. * Individuals who are inmates in psychiatric wards, prison or state institutions, or any individuals otherwise regarded as vulnerable (as per ISO 14155 Section 3.55). * Participation in another investigative drug or device study currently or within the last 30 days. * Current participation in a cosmetic study. * Employees of the investigation sites directly involved in this clinical investigation. * Employees of the sponsor's company. * Employees of a competitor company. The participant should not work for any company which produces dressings. * The participant is considered by the Investigator to be unsuitable to participate in the investigation for any other reason
Where it's running
-
SGS proderm GmbH
Schenefeld, Free and Hanseatic City of Hamburg, Germany Recruiting
Study contacts
- Principal investigator: Dr. Uta Solecke — SGS Proderm GmbH
- Study coordinator: Kristina Welinder
- Email: kristina.welinder@molnlycke.com
- Phone: +46 (0)31- 722 31 96
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pfizer medicine PF-08103402: how different doses are tolerated in healthy adults and adults with mild-to-moderate asthma
This study tests how different amounts of PF-08103402 behave in the body and how well it is tolerated by healthy adults and adults with mild-to-moderate asthma.
-
Focal muscle vibration to limit leg muscle weakness during reduced use
This trial will see if a 10-day program of focal muscle vibration can limit strength loss in healthy adults whose one leg is temporarily unloaded.
-
Kidney responses to exercise in heat and whether vitamin B3 changes them.
This project will test whether taking vitamin B3 changes how the kidneys respond when healthy, physically fit adults exercise in hot, humid conditions.
-
Assessing the safety of inhaling xenon gas in healthy volunteers
This study is testing if inhaling xenon gas is safe for healthy people to see if it could help in treating neurodegenerative diseases like Alzheimer's in the future.
-
Brain responses to gentle ear stimulation measured with near-infrared light
This one-visit test uses gentle ear stimulation and near-infrared head sensors to see how healthy adults' brains respond.
-
A program combining music and activities to promote healthy aging
This study is testing whether a program that combines music, exercise, and social activities can help older adults keep their minds sharp and improve their overall brain health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.